As per the report published by Allied Market Research, the LATAM Women Hypoactive Sexual Desire Disorder Treatment Market was pegged at $131 million million in 2019, and is projected to reach $170 million by 2027, growing at a CAGR of 3.8% from 2020 to 2027.
Increase in prevalence of lifestyle ailments, rise in use of medicines that induce HSDD, and surge in the number of surgical procedures that lead to sexual dysfunction drive the growth of the LATAM women hypoactive sexual desire disorder treatment market. However, lack of awareness regarding to HSDD hampers the market growth. On the contrary, presence of strong pipeline products is expected to create lucrative opportunities for the market players in the coming years.
Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/7952
Since announcements of the Covid-19 outbreak as a pandemic, several countries across the globe adopted lockdown and asked to observe social distancing as a preventive measure to curb the spread. This resulted in decline in logistic services.
On the other hand, the majority of the healthcare professionals and systems focused their attention on treating Covid-19 patients. Thus, most of the HSDD patients had to reschedule their doctor appointments.
However, several governments announced relaxation in lockdown measures. So, the demand for HSDD drugs is expected to increase and distribution activities would get back on track
On the basis of sales channel, the market is divided into hospitals, clinics, and online retailers. The hospitals segment dominated the market in 2019, contributing to nearly half of the market. However, the clinics segment is estimated to register the highest CAGR of 6.7% during the forecast period.
The LATAM women hypoactive sexual desire disorder treatment market is segmented on the basis of treatment type, sales channel, and country. Based on treatment type, the market is divided into buspirone, bupropion, bremelanotide, and flibanserin. The bremelanotide segment held the largest share in 2019, accounting for around three-fifths of the market. The same segment is expected to register the highest CAGR of 6.6% during the forecast period.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/7952
The LATAM women hypoactive sexual desire disorder treatment market report includes an in-depth analysis of the major market players such as Bristol-Myers Squibb Company, Aurobindo Pharma, Mylan N.V., GlaxoSmithKline Plc, Palatin Technologies, Inc., Novartis AG, Sun Pharmaceutical Industries Limited, Sprout Pharmaceuticals, Inc., Zydus Cadila, and Teva Pharmaceutical Industries Ltd.
The LATAM women hypoactive sexual desire disorder treatment market is analyzed across various regions such as Brazil, Argentina, Chile, Colombia, and the Rest of LATAM. The market across Brazil held the largest share in 2019, accounting for more than one-third of the market. However, the market across Argentina is projected to register the highest CAGR of 7.7% from 2020 to 2027.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060